Pharmafile Logo
Pharmafocus logo
Advanced Search

OxyContin

Showing 15 posts of 25 posts found.

Photo by Psiĥedelisto

Democratic Senators urge judge to reject Purdue Pharma’s proposal to pay CEO a bonus

September 22, 2020
Manufacturing and Production OxyContin, Purdue, Purdue Pharma

Democratic US Senators are urging Judge Robert D. Drain to reject Purdue Pharma’s proposal to pay CEO and President Craig …

News
920x920

Judge overseeing Purdue Pharma bankruptcy approves $1.3 million bonus for CEO

January 27, 2020
Sales and Marketing Election 2020, OxyContin, Purdue Pharma, US Presidential Race, fentanyl, opioid crisis

Purdue Pharma’s CEO Craig Landau can receive a $1.3 million bonus, ruled a judge. Judge Robert Drain said the company …

News
14281921538_bacbef11bc_b

Pharmacies argue that prescribers bear ultimate responsibility for the opioid crisis

January 8, 2020
Research and Development Bernie Sanders, OxyContin, opioid crisis, opioids

Pharmacy chains have argued in federal court that doctors and healthcare practitioners who write prescriptions bear ultimate responsibility for the …

News
19916066779_1a281ebca0_b

Johnson & Johnson sued by Washington State for role in the opioid crisis

January 3, 2020
Medical Communications Bernie Sanders, Johnson & Johnson, OxyContin, fentanyl, opioid crisis, opioids

The state of Washington sued pharmaceutical company Johnson & Johnson for deceptive marketing that said their opioids were effective for …

News
fdaoutsideweb_18

FDA fuelled opioid crisis by failing to police pharmaceutical companies, new study shows

January 2, 2020
Business Services FDA, Opioids Crisis, Opioids Trump, OxyContin, Trump Administration, opioids

The FDA’s Risk Evaluation and Mitigation Strategy (REMS), which began in 2012, failed to successfully police the companies creating opioids …

News
920x920

Sackler family withdrew $10 billion from Purdue Pharma while legal pressure mounted, audit shows

December 17, 2019
Manufacturing and Production Oxy, OxyContin, Purdue Pharma, Sackler family, opioid, opioid crisis, sackler

An audit commissioned by Purdue Pharma, to help navigate its bankruptcy, indicates that members of the Sackler family withdrew $10.7 …

News
OxyContin

Opioid drugmaker Purdue Pharma files for bankruptcy

September 16, 2019
Sales and Marketing OxyContin, Purdue Pharma

In the face of thousands of lawsuits in its role in the opioid addiction crisis, Purdue Pharma   announced yesterday that …

News
920x920

Sacklers could give up Purdue Pharma and settle 2,000 lawsuits for $10-12 billion, proposal says

August 28, 2019
Research and Development OxyContin, Purdue Pharma, Sackler family, opioid crisis, opioids, pharma

The Sackler family are offering to settle more than 2,000 opioid crisis lawsuits for between $10-12 billion, according to NBC. …

News
920x920

Sacklers file motion to throw lawsuit out of court

April 5, 2019
Medical Communications Massachusetts, OxyContin, Purdue Pharma, opioid crisis, opioids, sackler

Members of the Sackler family have asked a judge to throw a lawsuit – filed by Massachusetts attorney general Maura …

News
920x920

Sacklers fraudulently transferred funds to dodge litigation, lawsuit says

March 29, 2019
Medical Communications Litigation, New York, OxyContin, Purdue Pharma, Sackelr, opioids

New York state prosecutors have filed a lawsuit against members of the Sackler family, alleging the Purdue Pharma controllers fraudulently …

News
920x920

Purdue Pharma settle Oklahoma lawsuit for $270 million

March 26, 2019
Research and Development Oklahoma, OxyContin, Purdue Pharma, opioid crisis, oxycodone

OxyContin drugmaker Purdue Pharma has agreed to pay nearly $270 million to the state of Oklahoma, in order to settle …

News

Tate art galleries will not accept donations from Sacklers

March 22, 2019
Medical Communications OxyContin, Purdue Pharma, Sacklers, Tate, art galleries, opioid crisis

The Tate network of art galleries has said it will no longer accept gifts from the notorious Sackler family, the …

News
920x920

Purdue Pharma vow not to profit from fast tracked opioid overdose antidote

March 18, 2019
Sales and Marketing FDA, OxyContin, Purdue Pharma, nalmefene hydrochloride, opioids

The FDA has granted OxyContin drugmaker Purdue Pharma, fast track designation for opioid overdose antidote nalmefene hydrochloride (HCl) injection. However, …

News
opioid_pills

Reformulated OxyContin led to spike in Hepatitis C infections

February 5, 2019
Manufacturing and Production OxyContin, USA, hepatitis C, heroin, infectious diseases, opioids

Efforts to create an “abuse deterrent” OxyContin pill inadvertently led to an increase in the number of Hepatitis C infections, …

News
920x920

Purdue Pharma sought to expand into opioid addiction treatments while using McKinsey to counter “emotional messages”

January 31, 2019
Business Services, Medical Communications Massachusetts, OxyContin, Purdue Pharma, US, USA, opioids

OxyContin drugmaker Purdue Pharma explored expanding into the market for opioid addiction treatments, according to passages from court documents that …

News

Latest content

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024

AskBio initiates phase 2 Parkinson’s trial recruitment

June 26, 2024

AstraZeneca’s Tagrisso approved in Japan for lung cancer treatment

June 25, 2024

ILiAD Biotechnologies announces collaboration with Emmes Group on phase 3 pertussis vaccine trial

June 25, 2024

GSK’s Jemperli accepted for review by EMA for endometrial cancer treatment

June 24, 2024